Mounjaro®
Starting from £179.99/mo
Start journey Learn moreNo — Mounjaro cannot be started at 7.5 mg. The licensed schedule begins at 2.5 mg for the first four weeks, and 7.5 mg is only reached after at least eight weeks on lower doses. Skipping that sequence isn't a shortcut; it's the part of the plan that determines how well your body tolerates the medicine. Mounjaro is a prescription-only medicine, and every dose decision is made by a qualified prescriber based on your individual circumstances — not by a fixed rulebook applied to everyone.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
It's one of the most common questions a prescriber hears. Someone reads about Mounjaro, sees that meaningful weight loss tends to become more apparent at 5 mg and above, and wonders whether the 2.5 mg starting dose is just a formality they could skip. The reasoning feels logical. The answer, unfortunately, is no, and it's worth understanding why, because it changes how you think about the early weeks.
Mounjaro activates two receptors at once: GIP and GLP-1. That dual action is what makes it effective, but it also means your digestive system needs time to adjust. The 2.5 mg starting dose is there specifically to give your gut that adjustment period. Most of the nausea, vomiting and stomach discomfort that people associate with GLP-1 medicines is heavily concentrated in the first weeks of treatment and after each dose increase. Beginning at 2.5 mg significantly reduces the intensity of that response. If you started at 7.5 mg, you'd be asking your body to adapt to three dose-steps worth of effect at once, with no runway.
The NHS patient information for tirzepatide is clear on this: treatment starts at 2.5 mg and increases roughly every four weeks as tolerated, guided by your prescriber. That guidance exists because the people who try to move faster tend to experience more severe side effects, and some stop treatment altogether before reaching the doses that would have worked well for them. The early weeks are part of the treatment, not a preamble to it.
The licensed Mounjaro schedule runs: 2.5 mg for the first four weeks, then 5 mg for at least four weeks, then 7.5 mg for at least four weeks, and so on up through 10 mg, 12.5 mg and 15 mg if clinically appropriate. Reaching 7.5 mg takes a minimum of eight weeks from the day you start. That's not a long time in the context of a treatment intended to work over many months.
Some people stay at a given dose for longer than four weeks, either because their prescriber recommends it, or because they want more time before their next increase. That flexibility is built in. What isn't built in is the ability to begin at step three. The question of whether 2.5 mg is truly mandatory comes up often, and the answer is yes, it is the licensed starting dose, full stop.
If you're transferring from another provider and you're already established on 7.5 mg, that's a different situation. A prescriber at a regulated pharmacy like ours will ask for evidence of your current treatment before continuing at any dose above the starter level. That's not bureaucracy, it's part of making sure the clinical picture is complete before a prescriber puts their name to your next pen.
For many people, 7.5 mg represents a meaningful shift in appetite suppression. Clinical trial data from the SURMOUNT programme, published in the New England Journal of Medicine, showed increasing weight loss at each dose step, with the strongest results at 10 mg and 15 mg over 72 weeks. That doesn't mean 7.5 mg is ineffective, for some people, the balance of efficacy and tolerability is best at this level, and their prescriber may recommend staying there rather than continuing to increase.
It's also worth noting that 7.5 mg isn't a destination for everyone. Some people move through it quickly; others need longer. Prescribers look at how well you're tolerating the current dose, whether you're seeing progress, and what your overall health picture looks like. If you're curious about how the 5 mg dose fits into this picture, that's a natural part of the conversation at your first review. The point is that the decision is clinical, made with you, not a number you select from a menu.
If cost is a factor in your thinking about which dose to aim for, it helps to understand how Mounjaro is priced in the UK. Our Mounjaro pricing page sets out what's included in the cost at each dose level, so there are no surprises.
If you haven't yet started Mounjaro, the route through a regulated service like ours begins with a free consultation reviewed by a GPhC-registered prescriber. There's no algorithm sorting your answers, a real clinician reads them the same day. If you're clinically suitable, treatment is dispatched the same day for orders placed before 12pm Monday to Friday, arriving the next working day with DPD in plain, unbranded packaging.
Every repeat order is clinically reviewed before it goes out. Dose increases aren't automatic; they require a prescriber to be satisfied that the current dose is being tolerated and that moving up is appropriate. Many patients also ask whether they can start Mounjaro at 5 mg rather than the standard 2.5 mg beginning, and our prescribers can walk you through exactly why the titration schedule is set up the way it is. That process protects you, it's the reason people complete treatment rather than abandoning it at week three with unmanageable nausea.
If you'd like to understand more about how Mounjaro works before starting, or want to explore whether treatment is right for your situation, our clinical team is set up to answer questions properly. You can also read about the weight-loss treatments we offer to see where Mounjaro sits alongside other options. If you are still weighing up whether starting Mounjaro at 5 mg could be right for you, that is exactly the kind of question a prescriber can address during your free consultation. When you're ready, speak to our prescribers through a free consultation and get a clinical assessment the same day.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.